Actual Medicinal Product (AMP) - Glecaprevir 100mg / Pibrentasvir 40mg tablets (AbbVie Ltd)
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Glecaprevir 100mg / Pibrentasvir 40mg tablets | Start Date 14-06-2023 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
Code | Start Date | End Date |
---|---|---|
41965111000001104 | 14-06-2023 |
Parent Products
-
VTMGlecaprevir + Pibrentasvir
-
VMPGlecaprevir 100mg / Pibrentasvir 40mg tablets
-
AMP(Current) Glecaprevir 100mg / Pibrentasv... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
Pack Size | Indicative Price | Discontinued |
---|---|---|
84 tablet | 1299366 |